Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference18 articles.
1. Apostolaros M, Babaian D, Corneli A, et al. Legal, regulatory, and practical issues to consider when adopting decentralized clinical trials: recommendations from the clinical trials transformation initiative. Therap Innov Regul Sci. 2020;54:779–87.
2. Khozin S, Coravos A. Decentralized trials in the age of real-world evidence and inclusivity in clinical investigations. Clin Pharmacol Therap. 2019;106:25–7.
3. Kadakia KT, Asaad M, Adlakha E, et al. Virtual clinical trials in oncology—overview, challenges, policy considerations, and future directions. JCO Clin Cancer Inf. 2021;5:421–5.
4. Sommer C, Zuccolin D, Arnera V, et al. Building clinical trials around patients: evaluation and comparison of decentralized and conventional site models in patients with low back pain. Contemp Clin Trials Commun. 2018;11:120–6.
5. Gerke S, Shachar C, Chai PR, et al. Regulatory, safety, and privacy concerns of home monitoring technologies during COVID-19. Nat Med. 2020;26:1176–82.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献